Tizacare
Intended to relieve skeletal hypertonicity to support movement coordination and target spastic reflexes.
- Category
- Pain & Anti-inflammatories
- Active ingredient
- Tizanidine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 2mg
Prescription and consultation requirements for Tizacare vary by destination and are determined by the fulfilment partner.
Tizacare details
- Conditions
- Spasticity · Muscle Spasms
- Alternative names
- tizanidine
- Therapeutic class
- Alpha-2 Adrenergic Agonist
- Pharmacological class
- Centrally Acting Skeletal Muscle Relaxant
- Contraindications
- concurrent use of fluvoxamine or ciprofloxacin; severe hepatic impairment
- Minor side effects
- dry mouth; somnolence; dizziness
- Moderate side effects
- fatigue; hypotension; headache
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Ikon Remedies
- Onset Time
- 1–2 hours
- Duration
- 6–8 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Ciprofloxacin; Fluvoxamine; Alcohol
- Age restrictions
- Approved for adults.
Serious side effects
severe hepatotoxicity, requires immediate medical attention; severe orthostatic hypotension, requires immediate medical attention
Patient summary
intended to relieve skeletal hypertonicity to support movement coordination and target spastic reflexes.
Mechanism of action
Stimulates central presynaptic alpha-2 receptors, decreasing the release of excitatory amino acids to relax motor neurons.
Pregnancy and breastfeeding
TGA Category C: Use if potential benefits justify risks. Breastfeeding: Consult a doctor.